| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/27/2000 | WO1999061040A3 USE OF α1β1 INTEGRIN RECEPTOR INHIBITORS AND TGF-β1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 01/27/2000 | WO1999061008A3 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals |
| 01/27/2000 | WO1999060987A3 Control of pain with endogenous cannabinoids |
| 01/27/2000 | WO1999058527A3 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient |
| 01/27/2000 | WO1999056734A3 Transdermal therapeutic system for the administration of candesartan |
| 01/27/2000 | WO1999055388A9 Substituted porphyrins |
| 01/27/2000 | WO1999055317A3 Treatment of advanced decompensated heart failure with nitric oxide donors |
| 01/27/2000 | WO1999052925A9 Programmed cell death and caspase-12 |
| 01/27/2000 | WO1999051607A3 Process for purification of a cephalosporin derivative |
| 01/27/2000 | WO1999051238A9 Semi-synthetic ecteinascidins |
| 01/27/2000 | WO1999023227A9 Hyaluronan synthase gene and uses thereof |
| 01/27/2000 | WO1999017780A8 Dexamethasone gel |
| 01/27/2000 | DE19918588A1 Piperidinverbindung Piperidine |
| 01/27/2000 | DE19833476A1 New genetically modified, adherently growing CD34-negative stem cells for transfer of gene therapy constructs for treatment of immunodeficiency and metabolic disorders |
| 01/27/2000 | DE19833119A1 Storage-stable injectable solution of vasodilator and beta blocker Carvedilol contains buffer, organic solvent, antioxidant and complexing agent |
| 01/27/2000 | DE19833105A1 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents |
| 01/27/2000 | DE19832890A1 Pflegende kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettalkoholen Care cosmetic and dermatological preparations containing fatty alcohols |
| 01/27/2000 | DE19832519A1 Topical antiviral medicament for treating herpes infections, containing synergistic combination of adenosine and protein inhibiting antiviral agent, e.g. acyclovir |
| 01/27/2000 | DE19832191A1 New N-acylated ergoline amine derivatives, are alpha-1 adrenoreceptor blockers useful as potent, well tolerated antihypertensive agents |
| 01/27/2000 | DE19832169A1 Treating or preventing oral atrophic symptoms, e.g. marginal periodontal disease, by local administration of estrogen such as estriol |
| 01/27/2000 | DE19831878A1 New polycyclic thiazolidin-2-ylidene amines, are lipid metabolism regulators useful for treating obesity or type II diabetes |
| 01/27/2000 | DE19831798A1 Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement |
| 01/27/2000 | CA2674800A1 Polymorph of a pharmaceutical |
| 01/27/2000 | CA2343748A1 5-bicycloindole compounds |
| 01/27/2000 | CA2338122A1 Macrophage scavenger receptor antagonists |
| 01/27/2000 | CA2338059A1 Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent |
| 01/27/2000 | CA2338054A1 Bicyclohexane derivatives |
| 01/27/2000 | CA2338039A1 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
| 01/27/2000 | CA2338037A1 Compounds specific for the human .alpha.1d adrenergic receptor and uses thereof |
| 01/27/2000 | CA2337997A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | CA2337898A1 Agents for treating allergic diseases |
| 01/27/2000 | CA2337883A1 Method for regulating hair growth |
| 01/27/2000 | CA2337881A1 Novel ergoline amine derivatives and their use |
| 01/27/2000 | CA2337880A1 Substituted piperazinones and therapeutic uses thereof |
| 01/27/2000 | CA2337859A1 Novel agents for treating allergic diseases |
| 01/27/2000 | CA2337850A1 Alpha-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and their use for treating inflammation |
| 01/27/2000 | CA2337848A1 Compositions which contain triterpenes for regulating hair growth |
| 01/27/2000 | CA2337838A1 Polycyclic thiazolidin-2-ylidene amines, method for the production and use thereof as medicaments |
| 01/27/2000 | CA2337776A1 Bispiperidines as antithrombotic agents |
| 01/27/2000 | CA2337771A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 01/27/2000 | CA2337517A1 Novel dna-cleaving antitumor agents |
| 01/27/2000 | CA2337516A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
| 01/27/2000 | CA2337507A1 Composition for treatment of stress |
| 01/27/2000 | CA2337499A1 Methods for reducing intraocular pressure using a3-adenosine antagonists |
| 01/27/2000 | CA2337481A1 Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
| 01/27/2000 | CA2337436A1 Use of (s) (-)-amisulpride for the manufacture of a medicament for the treatment of schizophrenia |
| 01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
| 01/27/2000 | CA2337398A1 Nocathiacin antibiotics |
| 01/27/2000 | CA2337377A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2337351A1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 01/27/2000 | CA2337305A1 Diacylhydrazine derivatives |
| 01/27/2000 | CA2337256A1 Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents |
| 01/27/2000 | CA2337229A1 Method of treatment |
| 01/27/2000 | CA2337194A1 Preparation of (s)-2-amino-6,6-dimethoxyhexanoic acid methyl ester via novel dioxolanes |
| 01/27/2000 | CA2337179A1 Therapeutic composition based on flavonoids, intended to be used in the treatment of tomours by cytotoxic |
| 01/27/2000 | CA2337138A1 Compositions and methods of treating abnormal cell proliferation |
| 01/27/2000 | CA2337119A1 Antiparasitic artemisinin derivatives (endoperoxides) |
| 01/27/2000 | CA2337115A1 Pharmaceutical compositions comprising 2-quinolones |
| 01/27/2000 | CA2337049A1 New pharmaceutical preparation and method |
| 01/27/2000 | CA2336998A1 Medicinal product and method for treatment and prevention of dyskinesia |
| 01/27/2000 | CA2336950A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 01/27/2000 | CA2336143A1 Aminoalkylphosphonic acid derivatives and their use in treating infections |
| 01/27/2000 | CA2334811A1 Oxazolidinones to treat eye infections |
| 01/27/2000 | CA2334161A1 Use of nucleic acid molecules as antiviral agents |
| 01/27/2000 | CA2333931A1 Polysaccharide vaccine for staphylococcal infections |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2313789A1 Soy formulations and their use for promoting health |
| 01/27/2000 | CA2303946A1 Chemical composition having spermicidal, bactericidal and virucidal activity and apparatus for delivery into the vaginal canal |
| 01/27/2000 | CA2303786A1 Freeze-dried product and method for preparing the same |
| 01/26/2000 | EP0974664A2 Human polypeptides and polynucleotides homolog to mouse testes-specific angiotensins converting enzyme |
| 01/26/2000 | EP0974663A1 Lipoprotein associated phospholipase A2, inhibitors thereof and use of same in diagnosis and therapy |
| 01/26/2000 | EP0974659A2 Viral nucleotide sequences |
| 01/26/2000 | EP0974598A2 New erythromycin derivatives, process for making them and their use as medicines |
| 01/26/2000 | EP0974593A1 Artemisinin derivatives as antiparasitic agents |
| 01/26/2000 | EP0974586A1 2-amino-4-alkylamino-pyrimidine 3-oxydes and compositions containing same |
| 01/26/2000 | EP0974580A1 Omega-cycloalkyl-prostaglandin E1 derivatives |
| 01/26/2000 | EP0974573A1 Phenylpropenone compounds and medicines containing the same |
| 01/26/2000 | EP0974363A1 Remedies for drug addiction |
| 01/26/2000 | EP0974361A1 Method of using antacid agent and pharmaceutical preparation containing antacid agent |
| 01/26/2000 | EP0974356A1 Tablets comprising a combination of metformin and glibenclamide |
| 01/26/2000 | EP0974355A1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same |
| 01/26/2000 | EP0974353A2 The use of homocysteine derivatives for the preparation of medicaments inhibiting bacterial adhesiveness |
| 01/26/2000 | EP0974352A1 Drugs inhibiting progress of pterygium and postoperative recurrence of the same |
| 01/26/2000 | EP0974351A2 Medicament for preventing and treating gastrointestinal damage |
| 01/26/2000 | EP0974350A1 External preparation containing tranilast and process for producing the same |
| 01/26/2000 | EP0974349A1 Athletic endurance increasing agent |
| 01/26/2000 | EP0974348A1 Visceral fat lowering agent |
| 01/26/2000 | EP0974347A1 Antiviral agents |
| 01/26/2000 | EP0974344A2 Composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides |
| 01/26/2000 | EP0974343A1 Metoprolol composition and processes for manufacturing the same |
| 01/26/2000 | EP0974339A2 Cosmetic and dermatological care compositions containing fatty alcohols |
| 01/26/2000 | EP0974335A1 Cosmetic detergent compositions and their use |
| 01/26/2000 | EP0974058A2 20 human secreted proteins |
| 01/26/2000 | EP0973942A2 Screening method for proline-rich proteins |
| 01/26/2000 | EP0973925A2 Matrix derived anti-hiv peptides and transdominant proteins |
| 01/26/2000 | EP0973903A2 Protein for inhibiting apoptosis |
| 01/26/2000 | EP0973902A1 Radioisotope concentrator methods and compositions |
| 01/26/2000 | EP0973894A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 01/26/2000 | EP0973886A2 METHOD AND CONJUGATE FOR TREATING $i(H. PYLORI) INFECTION |